deCODE genetics, Inc. (Nasdaq: DCGN) today announced
that it will report its second quarter 2006 financial
results in a press release to be issued on Tuesday,
August 8, after the close of the market in New York.
The company will host a live webcast of its conference
call to discuss the financial results and recent operating
highlights on Wednesday, August 9, at 8am Eastern Daylight
time/12 noon GMT.
The webcast can be accessed through the Investors page
of deCODE's website, http://www.decode.com, or through
http://www.earnings.com. Please log in to the webcast
15 minutes prior to the scheduled start of the call.
The call will be archived for at least a week on each
site. For those unable to listen to the webcast because
of company firewall or other issues, a digitized audio
replay will also be available by telephone from approximately
12:30pm EDT on Wednesday, August 9 and for one week
thereafter. The dial-in replay numbers are: 1 (800)
475-6701 in the U.S., and +1 (320) 365-3844 for those
calling from outside the U.S. The access code is 838195.
About deCODE
deCODE is global leader in applying human genetics to
develop drugs for common diseases. Our population approach
has enabled us to discover and target key biological
pathways involved in conditions ranging from heart attack
to cancer. We are turning these discoveries into new
medicine to better treat and prevent many of the biggest
challenges to public health. deCODE is delivering on
the promise of the new genetics.SM Visit us on the web
at www.decode.com.
Any statements contained in this presentation that relate to future plans,
events or performance are forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995. These forward-looking
statements are subject to a number of risks and uncertainties that could cause
actual results to differ materially from those described in the forward-looking
statements. These risks and uncertainties include, among others, those relating
to technology and product development, integration of acquired businesses,
market acceptance, government regulation and regulatory approval processes,
intellectual property rights and litigation, dependence on collaborative relationships,
ability to obtain financing, competitive products, industry trends and other
risks identified in deCODE’s filings with the Securities and Exchange Commission.
deCODE undertakes no obligation to update or alter these forward-looking statements
as a result of new information, future events or otherwise.
